The MS Trust has launched the role of an ‘Advanced MS Champion’ to help bridge the gap in care services for people with advanced multiple sclerosis (MS).
The MS Trust estimates that approximately 40,...
Researchers at Stanford University School of Medicine have proved that a system they developed a few years ago for culturing balls of stem-cell-derived human brain cells, which mimic aspects of real...
According to a recent study, linuron, a herbicide used with other herbicides, insecticides and fungicides to control the growth of grass and weeds, may be an important environmental risk factor in...
GeNeuro, a biopharmaceutical company, developing new treatments for neurological and autoimmune diseases such as multiple sclerosis (MS) and type-1 diabetes, has announced positive safety and...
Researchers from Charité - Universitätsmedizin Berlin have discovered how the body initiates repair mechanisms which will limit the extent of any damage to the myelin sheath caused by multiple...
A recent study of relapsing remitting multiple sclerosis patients treated with fingolimod, natalizumab, or alemtuzumab found they were less likely to convert to secondary progressive MS (SPMS)...
A preliminary study of nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) has found it to be more effective than disease-modifying therapy (DMT) for patients with relapsing remitting...
Brain volume loss in multiple sclerosis (MS) is primarily driven by grey matter changes and may be independent of clinically effective treatment, a new study reports.
Brain volume loss is an...
A small molecule, Sephin1, may be able to significantly delay harm to nerve cells caused by multiple sclerosis (MS) a study has shown.
Nerve fibres are wrapped in a sheath of fatty tissue called...
Cardiorespiratory fitness has previously been associated with disease severity, walking capacity and comorbidities in people with multiple sclerosis (MS). However, current evidence is of moderate...
